Nobel Laureate Thomas Südhof and bit.bio CEO Mark Kotter to Lead Fireside Chat on Programming Human Cells at SynBioBeta
CAMBRIDGE, England--(BUSINESS WIRE)--Cell coding company bit.bio today announces the key appointment of Kathryn Corzo as Chief Operating Officer. She started in the role on 1 November 2021.
UK-based bit.bio has raised $103m through a Series B funding round to accelerate the clinical development of cell therapies.